NCCS Logo
 
Hotline
HELP DESK : +65 6436 8000   CANCER HELPLINE : +65 6225 5655
 Hotline

Home    |    Contact Us   |   Join Us   |   Sitemap  
  About Us       News Room        Events       Cancer Information       Publications       Tenders       Useful Links       Donate / Volunteer
Dottedline
MastHead-Level1
 

Overview
Dotted_Sidemenu
Institutional Review Board (IRB)
Dotted_Sidemenu

Research Programmes
Dotted_Sidemenu
Research Collaborators
   

Local Collaborators
  dotted_150
Arrow_green
 International Collaborators
   
Dotted_Sidemenu
Research News
Dotted_Sidemenu
Research Publications
Dotted_Sidemenu
Research Conferences
Dotted_Sidemenu
Invited Lectures
Dotted_Sidemenu
Research Awards
Dotted_Sidemenu
Donating towards Research
Dotted_Sidemenu
 
Home > For Researchers > Research Collaborators > International Collaborators
 
International Collaborators
 
PRINCIPAL INVESTIGATOR/
LABORATORY		 INTERNATIONAL COLLABORATORS RESEARCH CENTRE PROJECT TITLE
PROF HUI KAM MAN


Bek Chai Heah Laboratory of Cancer Genomics		 Prof H Kim Lyerly Duke Comprehensive Cancer Centre, USA Hepatocellular Carcinoma
Prof Walter Gunzburg Research Institute of Virology and Biomedicine, University of Veterinary Medicine; Vienna, Austria
Prof Farzin Farzaneh The Rayne Institute, King’s College, UK Gene therapy of cancer
 

DR PAULA LAM

Laboratory of Cancer Gene Therapy

 Prof Xandra Breakefield Harvard Medical School, Massachusetts General Hospital-East, USA Generation and characterization of chimeric viral vectors gene therapy for pre-clinical studies.
A/Prof Fraefel C University of Zurich, Switzerland Characterization of pYEBac102 recombinants
Prof Abhijit Guha University of Toronto, Hospital for Sick Children Towards a better understanding of human gliomas
Dr Bakhos A Tannous Harvard Medical School, Massachusetts General Hospital-East, USA
PROF MALCOLM PATERSON

Laboratory of Genome Maintenance
 Dr Sibghat-Ullah Lari Department of Biological and Medical Research, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia Initiation of strand incision at a G:T mismatch in model DNA by human cells: Characterization of a novel ATP-dependent pathway
Dr Futwan A Al-Mohanna Triggering the calcium transient by non-ionizing (far UV) radiation
Dr Razmik Mirzayans Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada Characterization of the prostaglandin E2-activated signaling pathway mediating the correction of RDS in ataxia telangiectasia fibroblasts
Dr Brian J Druker Oregon Cancer Institute, Oregon Health Sciences University, Portland, Oregon, USA Phosphoproteomic Identification of human tumor signalling susbtrates in vitro and in vivo: comparison
with quiescent cells and normal tissues
Dr A Price Department of Oncology, University of Edinburgh, UK Radiobiological accuracy & uncertainty
Dr NACS Wong
Dr H Monahan Department of Pathology, University of Edinburgh, UK
Dr DJ Harrison
A/PROF HUYNH THE HUNG

Laboratory of Molecular Endocrinology		 Dr Samuel Freedman Lady Davis Institute for Medical Research, McGill University, Canada Hormonal aspect of breast cancer
Dr Michael Pollak Breast Cancer Prevention Centre, McGill University, Canada Anti-estrogens in breast cancer treatment and preventation
Dr Gerald Batist Translational Research Centre, McGill University, Canada Chemo-preventation of breast and liver cancers
Dr Laurence Panasci Department of Medicine, McGill University, Canada Uses of SarCNU in the treatment of Hepatocellular Carcinoma
Dr Mostafa Elhilali McGill University, Canada IGF systems in bladder hypertrophy and bladder cancer
Dr Van Tan Binh Dan Hospital, Viet Nam Hepatitis B and C infection and liver cancer in Vietnam
Dr Khin Maung Win Yangon General Hospital, Myanmar Insulin-like growth factor binding prolteins in HCC
A/PROF PATRICK TAN

Laboratory of Molecular Genomics		 Dr Phillippe Broet University of Paris Genomics of Lung Cancer
Dr Sophie Camilleri-Broët
Dr Heike Grabsch University of Leeds, UK Molecular Genomics of Upper GI Cancers
 
A/PROF KANAGA SABAPATHY

Laboratory of Molecular Carcinogenesis		 Dr Roger Reddel Children’s Hospital Research Centre, Melbourne, Australia Effects of telomerase on the longetivity and senescence of mouse primary cells
Dr Maria Sibilia University of Vienna, Austria Regulation of differentiation and embryonic development by p53
Dr Erwin Wagner Institute of Molecular Pathology, Vienna, Austria Role of p53 in ES cell differentiation
Role of JNKs in development, growth and apoptosis
Dr Yoichi Taya National Cancer Centre, Tokyo, Japan Analysis of phosphorylation status of p53 and its effects on p53 regulation
Dr Saturo Kyo Dept. of Obstetrics, University of Kobe, Japan Telomerase promoter regulated tumor therapy
Dr Axel Behrens University of Zurich, Switzerland & Imperial cancer Research Fund, UK Function of phosphorylation of c-Jun in T lymphocyte development and tumorigenesis
Dr Massimo Broggini University of Milan, Italy Studies on p53/p73
Prof Alex Pintzas National Helenia Research Foundation, Athens, Greece Role of c-Jun/JNK in cellular signalling
Prof Robert Silverman Case Western Reserve University, Cleaveland, Ohio, USA Roles of JNK-induced apoptosis
Prof Stanley Cohen Stanford University, USA Identification of upstream activators of p53
Dr Isabella Graef Beckmann Centre, Stanford University, USA Role of NF-AT in JNK mediated fucntions in T cells
Dr Moshe Yaniv Pasteur Institute, France Role of JNKs in regulation of p53/mdm2 & cell migration
Dr Jonathan Weitzman
Dr Fukunaga Rikiro Osaka University, Japan Genetic screen to identify JNK targets
Dr Karen Vousden Beatson Institute, Glasgow, UK Regulation of p73
Dr Luzia Fischer Polish Academy of Sciences Role of p53 polymorphism in Caucasian population
Dr Rene Bernards Dutch Cancerer Institute (NKI) Role of DUBs in rgualtion of p73 and cJun stability
Dr Zhao Qi Wang IARC, Lyon, France Mouse models for p53 & human cancer
DR GANESAN GOPALAN

Laboratory of Gene Structure
& Expression		 Dr Peter J Donovan University of California, Irvine, USA Generation of Aurora-A knockout mice
 
A/PROF KON OI LIAN

Laboratory of Applied Human Genetics		 Sir Roy Calne Cambridge University, UK Gene- & cell-based treatment of diabetes
Dr Tai-Tung Yip Ciphergen Biosystems Inc., USA Protein profiling of gastric fluid
Dr Sun Young Rha Yonsei Cancer Center, Seoul, Korea Spectral karyotyping of gastric cancer cells
Dr Fan Hong & Dr Guo Qiang The First People’s Hospital of Yunnan, China Gastric fluid cytology and protein profiling
Crusade Laboratories Glasgow, Scotland, UK Gene therapy vectors
Poetic Genetics, Inc. Burlingame, California, USA Site-specific recombination system
PROF SOO KHEE CHEE & A/PROF MALINI OLIVO

Tan Chin Tuan Laboratory of Optical Imaging & Photodynamic Therapy		 Prof Martin Harris Melbourne University / Optiscan Endomicroscopy using fluorescent markers & 2-Photon Endoscopy
Prof Qian Peng Dept of Pathology, The Norwegian Radium Hospital, University of Oslo, Montebello, 0310 Oslo, Norway Photobiology
Prof Baumgartner Physicist, Laser Forschungslabor, Urologische Klinik der LMU, Marchioninistr. 23, D-81377
Munich, FRG		 Biophotonics instrumentation in cancer diagnosis
Prof Tayabba Hasan Wellman Labs of PhotoMedicine, Harvard Medical School, USA Photomedicine
Dr Manfred Haupt Haemato Science GmbH, Biotechnologiepark, 14943 Luckenwalde Germany Fotolon (chlorin e6) as a pharmaceutical agent
Prof Britton Chance University of Pennsylvania Biophotonics instrumentation in cancer diagnosis
Prof Steven Bown University College Hospital, London, UK & Ark Therapeutics, UK Plc Photodynamic therapy
Prof Sune Svanberg University of Lund, Sweden Biophotonics instrumentation in cancer diagnosis
Dr Othmar Dill Serapeutics, Germany PDT and Immunology
Prof Khin Maung Win Dept of Heptology, Yangon General Hospital, Myanmar AHCC01
Prof Phillip Johnson Dept of Clinical Oncology, Chinese University of Hong Kong
A/Prof Thomas Leung
Dr Tjakra Wibawa Manuaba Dept of Surgery, School of Medicine, University
of Undayana, Bali, Indonesia
Dr Thiravud Khuhaprema National Cancer Institute, Bangkok, Thailand
Prof Haron Ahmad Dept of Surgery, University Kebangsaan
Malaysia, Kuala Lumpur, Malaysia
A/Prof Michael Findlay Wellington Regional Oncology Unit, Wellington
Dr Si-Hyun Bae St Vincent’s Hospital, Catholic University of Korea, South Korea
A/Prof Johnathan Cebon Austin and Repatriation Medical Centre, Melbourne, Australia

A/PROF ANN LEE

Laboratory of Molecular Oncology		 Prof Joe Gray University of California, San Francisco, USA Array CGH analysis of Cancer
A/Prof Els Robanus-Maandag Centre for Human & Clinical Genetics, Leiden University Medical Centre (LUMC)
Prof Calvin Pang Dept of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong Mutational spectrum of BRCA 1 and BRCA2 genes in breast cancer
Dr Christina Rudduck-Sivaswaren Children’s Hospital at Westmead, Sydney FISH and array CGH analysis of cancer
Dr Nick Paton Clinical Trials Unit, Medical Research Council, UK Molecular analysis of Mycobacterium tuberculosis
A/PROF CAROLINE LEE

Laboratory of Liver Cancer Functional Genomics		 Dr Kuan-Teh Jeang National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA Functional Genomics of HCC
Dr Linda Lee Johns Hopkins University School of Medicine, USA
Dr Michael Gottesman National Cancer Institute, National Institutes of Health, USA Genetics of ABC transporters
 
A/PROF LONDON LUCIEN OOI

Laboratory of Liver Cancer Functional Genomics		 Dr Llew Keltner LightSciences Corporation, USA LSC-OL004 - A phase 1/2 open-label study to evaluate safety and prelimninary evidence of LED in the treatment of subjects with inoperable HCC
Dr Jay Winship
Dr James Chen A Phase 3 Randomized Study to Evaluate Survival
of Patients Treated with Talaporfin Sodium (LS11)
and Interstitial Light Emitting Diodes (LED) as
Compared to the Standard of Care Therapies in
the Treatment of Unresectable Hepatocellular
Carcinoma (HCC)
Dr Sy-Shi Wang  
Dr Stephen Barker University College Hospital, London, UK & Ark Therapeutics, UK Plc Trial on EO-impregnated wound dressings
DR MAC HO MENG FATT

Laboratory of Oncoproteomics		 Dr Robert H Brown Jr Massachusetts General Hospital-East, Harvard Medical School, USA Proteomic Analysis of Dysferlinopathy
Dr Gregory A Cox The Jackson Laboratory, USA
Dr Hart GW Lidov Children’s Hospital, Harvard Medical School, USA
Prof Anthony P Monaco The Wellcome Trust Centre, Oxford, UK Neuroacanthocytosis syndromes
Dr Soohee Lee New York Blood Center, NY, USA
Dr Colvin Redman
Dr Adrian Danek Munich, Germany
Dr Heike Grabsch Leeds University, UK Proteomic Approaches for Biomarker Discovery in
Gastric Cancer
 
DR BALRAM CHOWBAY

Laboratory of Clinical Pharmacology		 Dr Alex Sparreboom National Institutes of Health, USA Pharmacokinetics & pharmacogenetics in cancer Laboratory of Clinical
therapy
Dr Howard McLeod Washington University in St Louis School of Medicine, USA Pharmacogenetics in cancer patients
Dr Etienne Chatelut Institute Claudius Regaud, France Pharmacokinetics
Dr Zhou Shufeng Queensland Univ of Technology Pharmacokinetics & pharmacogenetics in cancer
therapy
DR JOSEPH WEE

Head, Division of Clinical Trials & Epidemiological Sciences		 Dr Winnie Yeo Dept of Clinical Oncology, Chinese University of Hong Kong A Phase I /II study of PXD101 in patients with unresectable hepatocellular carcinoma with pharmacokinetic and pharmacodynamic evaluation
Dr Anthony Chan
Dr Alex Chang Johns Hopkins Singapore Int Med Centre
Dr Tony Mok Dept of Clinical Oncology, Chinese University of Hong Kong
Dr Benny Zee
Dr Hyun Cheol Chung Division of Haematology-Oncology, Yonsei Cancer
Centre, Yonsei University College of Medicine.
Dr Pun Hui Dept of Clinical Oncology, Chinese University of
Hong Kong
Dr Lisa Horvath Sydney Cancer Centre, Royal Prince Alfred Hospital
Dr Hei Cheul Jeung Yonsei Metastasis Research, Yonsei Cancer Centre
Dr Brigette Ma Dept of Clinical Oncology, Chinese University of
Hong Kong
Dr Michael Millward School of Medicine and Pharmacology,
University of Western Australia, Sir Charles
Gairdner Hospital
Dr Michael Boyer Sydney Cancer Centre, Royal Prince Alfred Hospital
Dr Sun Young Rha Division of Haematology-Oncology, Yonsei Cancer
Centre, Yonsei University College of Medicine
Dr Jae Kjung Roh Division of Haematology-Oncology, Yonsei Cancer Centre, Yonsei University
College of Medicine
Dr Qian Tao Cancer Epigenetics Lab, Dept of Clinical Oncology, Chinese University Of Hong Kong
Dr Simon Chung Ho Yu Dept of Diagnostic Radiology and Organ
Imaging, Chinese University of Hong Kong
Dr Ka-Fai To Dept of Anatomical and Cellular Pathology, Chinese University of Hong Kong
Dr Brigette Ma Dept of Clinical Oncology, Chinese University of Hong Kong A phase II study of triapine and gemcitabine as second-line treatment of advanced non-small cell lung cancer in patients who had prior gemcitabine with evaluation of the effect of triapine on gemcitabine pharmacokinetics and cellular uptake in peripheral mononuclear cells
Dr Tony Mok
Dr Michael Boyer Sydney Cancer Centre, Royal Prince Alfred Hospital
Dr Anthony Chan Dept of Clinical Oncology, Chinese University of Hong Kong
Dr Alex Chang Johns Hopkins Singapore Int Med Centre
Dr Stephan Clarke Sydney Cancer Centre, Royal Prince Alfred Hospital
Dr KC Lam Dept of Clinical Oncology, Chinese University of
Hong Kong
Dr Ann D King Dept of Diagnostic Radiology and Organ Imaging, Chinese University of Hong Kong
Dr Anil T Ahuja
Dr Benny Zee Dept of Clinical Oncology, Chinese University of
Hong Kong
Dr Richard Ambinder Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins Cancer Research, Baltimore A Phase I trial of 5- Azacitidine and Suberoylanilide hydroxamic acid in patients with Metastatic or Locally Recurrent Nasopharyngeal Carcinoma and Nasal NK-T cell Lymphoma
Dr Anthony Chan Dept of Clinical Oncology, Chinese University of Hong Kong
Dr Alex Chang Johns Hopkins Singapore Int Med Centre
Dr Brigette Ma Dept of Clinical Oncology, Chinese University of Hong Kong
Dr Edwin Hui
Dr Qian Tao Cancer Epigenetics Lab, Dept of Clinical
Oncology, Chinese University Of Hong Kong
Dr Steve Gore Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins Cancer Research, Baltimore
Dr Michael Carducci
Dr Elizabeth Garrett-Mayer Johns Hopkins School of Medicine, Dept of
Oncology, Division of Biostatistics, Baltimore

DR TAN SAY BENG

Senior Biostatistician
Dr Steven Julious University of Sheffield, UK Early phase clinical trials
Prof Mike Campbell Clinical Trial Designs
Prof Peter Fayers University of Aberdeen, UK Quality of Life Studies
DR GAO FEI

Biostatistician		 Prof David Machin United Kingdom Children’s Cancer Study Group, University of Leicester, UK Double-peaked mortality risk following mastectomy for breast cancer in Singaporean women: Confirmation of findings from other
regions
Prof David Machin Kernel smoothing methods
Prof David Machin Seasonality of lymphomes
Prof David Machin On the evidence for seasonal variation in the onset
of acute lymphoblastic leukaemia (ALL)
Dr Rubert Jakes Department of Public Health and Primary Care, University of Cambridge, UK Follow-up of the Singapore Breast Screening Project: Efficacy, Disease Progression and Mammographic Density
Dr Cheung Yin Bun London School of Hygiene and Tropical Medicine, University of London, UK Quality of Life research
Prof Mini Yu Norris Comprehensive Cancer Center, University of Southern California, USA Dietary and Genetic Determinants of Mammographic Density
 
MS HEE SIEW WAN

Biostatistician		 Prof David Machin United Kingdom Children’s Cancer Study Group, University of Leicester, UK Phase II oncology trials with time-to-event endpoints
 
DR HA TAM CAM

Epidemiologist		 Prof David Machin University of Leicester, UK Oral Lichen Planus and Squamous Cell Carcinoma
Dr Nguyen Ky-Anh Biochemistry and Molecular Biology, University
of Georgia, Georgia, USA



 

 
MastHead_Level1_Bottom
 
 
  Disclaimer | Privacy | Terms of Use
Copyright © 2007 National Cancer Centre. All Rights Reserved.